Form D · Biotechnology

MAINZ BIOMED N.V.

Mainz, 2M · CIK 0001874252

Offering snapshot reported May 10, 2024 · SEC filing

Reported sold
$14.3M
Offering amount: $50M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 28, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.15M$14.3MJul 11, 2023: $5,500,000.00Jul 11, 2023May 10, 2024: $14,300,000.00May 10, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,500,000 → $14,300,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 10, 2024Amendment$14,300,000$8,800,000vs Jul 11, 20231SEC filing
Jul 11, 2023Initial$5,500,000No comparison1SEC filing
Sep 8, 2021InitialYet to sellNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-486514
Offering of $3,300,000 of ordinary shares under pre-paid advance agreement via promissory note convertible up to 4,166,667 shares at conversion price of $1.20 (subject to a reset date and floor) until four-month anniversary of the promissory note.

Source: Form D, filed May 10, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Guido Baechler Director, Executive
William Caragol Executive
Heiner Dreismann Director
Moritz Eidens Director, Executive
Phillip Freese Executive
Hans Hekland Director
Nicole Holden Director
Darin Leigh Executive
Alberto Libanori Director
Marco Messina Director
Gregory Tibbits Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Robert Koch Strasse 50
Mainz, 2M, 55129